Table 1.
Demographic characteristics in IVIG-responsive group and IVIG-resistant group in Kawasaki disease
*Days with documented fever before initiation of IVIG treatment. M: male, F: female, IVIG: intravenous immunoglobulin
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.